(Reuters) – Biogen Inc is providing its controversial and expensive new Alzheimer’s drug free of charge for some patients amid
Read moreHome »
Alzheimer
X Marks the Spot: Chromosome Genes Protective Against AD?
The X chromosome is associated with important measures of the brain in aging and Alzheimer’s disease (AD) in sex-specific ways,
Read moreDiabetes Drugs Tied to Less Amyloid, Slowed Cognitive Decline
Among patients with cognitive impairment, those with diabetes who took dipeptidyl peptidase-4 (DPP-4) inhibitors had less amyloid beta (Aβ) in
Read morePandemic Amplifies Urgent Need for Long-term Care Reform
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. DENVER ― Experts are calling the
Read morebuy generic cymbalta australia without prescription
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. DENVER ― Experts are calling the
Read moreStaggering Increase in Global Dementia Cases Predicted by 2050
DENVER ― Around the world, cases of dementia are projected to hit 153 million in 2050, up from around 57
Read moreCalculator Validated for Home-Based Dementia Risk Screening
(Reuters Health) – An online calculator may be an effective way for community-dwelling adults to screen for dementia risk at
Read moreFDA Updates Label for Controversial Alzheimers Drug Aduhelm
The US Food and Drug Administration (FDA) has approved an updated label for the controversial Alzheimer’s drug aducanumab (Aduhelm), emphasizing
Read moreLilly to Seek FDA Approval for Potential Alzheimers Drug
INDIANAPOLIS (AP) — Eli Lilly is nearly ready to take another shot at getting approval for a possible Alzheimer’s drug.
Read moreFDA Leader Explains Rationale Leading to Alzheimer Drug Approval
The US Food and Drug Administration (FDA) has provided a detailed and documented account of how it arrived at its
Read more